About this trial
As Taiwan transitions into a super-aged society, rising dementia rates have severely strained long-term care systems. Although current daycare centers provide multi-modal programs, they remain limited to behavioral training, lacking precise interventions targeting brain function and neuroplasticity or integrated non-invasive neuromodulation technologies. Furthermore, urban-rural disparities in resources, staffing allocation, and tech experience hinder practical deployment, with empirical research remaining scarce. Addressing this gap, this study investigates a smart brain health promotion model combining personalized gamma music stimulation and cognitive training for mild cognitive impairment and dementia, while evaluating its feasibility across diverse care settings.
Eligibility criteria
Qualifiers
Aged ≥ 60 years
The score of MoCA between 10 to 25
Disqualifiers
Diagnosis of other psychiatric or neurological disorders, and those with a history of neurological or psychiatric disorders that may affect cognitive assessment or performance. For example (but not limited to): Parkinson's disease, schizophrenia, major depressive disorder, epilepsy, severe traumatic brain injury with loss of consciousness, and stroke.
Drug, Nicotine or alcohol addictions
Serious heart, liver or kidney disorders, and visual, auditory or motor impairments interfering with neuropsychological tests.
Trial design
Treatments tested in this trial
- Digital personalized intervention system (active setting)
- Gamma auditory stimulation device (active setting)
- Gamma auditory stimulation device (sham setting)
Treatment groups
6
Treatment groupsSee each treatment group below.